ACCUSTEM SCIENCES, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -103.1% | -103.1% | -49.6% |
| FY2022 | 2,684.6% | 2,684.6% | -398.7% |
| FY2023 | 97.1% | 97.1% | -1,531.5% |
| FY2024 | 45.4% | 45.4% | -2,959.8% |
| FY2025 | 51.6% | 51.6% | -113.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -103.1% | -103.1% | -49.6% |
| FY2022 | 2,684.6% | 2,684.6% | -398.7% |
| FY2023 | 97.1% | 97.1% | -1,531.5% |
| FY2024 | 45.4% | 45.4% | -2,959.8% |
| FY2025 | 51.6% | 51.6% | -113.3% |